Alphanosos

Alphanosos - Leader in botanical plant-based natural antimicrobial control, well-being and medicine

Posted by Pascal from AlphanososResponsive · Investment Opportunities in Startups and Spinoffs · France

Summary of the technology

Alphanosos is active in animal feed, medical foods, and pharma, and with the right venture partners, to become a leader in botanical plant-based natural antimicrobial control, well-being and medicine through its R&D based on proprietary Artificial Intelligence. Alphanosos’ first patent-pending discoveries are incorporated into commercial products and generate its first revenues.

Description of the technology

Alphanosos is a privately held company incorporated in November 2014 in France.

We are leveraging our disruptive, AI-based, proprietary discovery process to discover and patent active ingredients and products based on plants with a history of safe human consumption to replace, with superior efficacy and reduced risks of side effects, many of the chemical products used as therapeutic drugs in the human and animal health industries.

We concentrate our discovery efforts on the selective killing of deleterious micro-organisms and cells. Our initial focus is on new antibiotics and anti-cancer products, with first products already in the post-discovery phase and a first patent application on anti-staphylococci products, for which we already obtained topical and systemic animal model results.

Early revenue is already generated by licenses for cosmetic usage of certain of these products, to be soon followed with licenses for veterinary applications and later for human drugs.

Intellectual property status

Patent pending in 71 countries.

Patent number : WO2018083115

Use of Proceeds

See presentation

Technology Owner

Alphanosos

Small and Medium Enterprise

Additional information (attached documents)

Related keywords

  • Care, Hygiene, Beauty, Cosmetics
  • Biological Sciences
  • Cytology, Cancerology, Oncology
  • Agriculture and Marine Resources
  • Agrofood Industry
  • Food Additives/Ingredients/Functional Food
  • Protecting Man and Environment
  • Computer related
  • Medical Health related
  • Food & feed ingredients
  • Consumer related
  • Health and beautty aids, Cosmetics
  • cancer

About Alphanosos

Small and Medium Enterprise from France

Alphanosos is a privately held company incorporated in November 2014 in France. We are leveraging our disruptive, AI-based, proprietary discovery process to discover and patent active ingredients and products based on plants with a history of safe human consumption to replace, with superior efficacy and reduced risks of side effects, many of the chemical products used as therapeutic drugs in the human and animal health industries. We concentrate our discovery efforts on the selective killing of deleterious micro-organisms and cells. Our initial focus is on new antibiotics and anti-cancer products, with first products already in the post-discovery phase and a first patent application on anti-staphylococci products, for which we already obtained topical and systemic animal model results. Early revenue is already generated by licenses for cosmetic usage of certain of these products, to be soon followed with licenses for veterinary applications and later for human drugs.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.